---
title: Prognostic significance of EGFR, AREG and EREG amplification and gene expression
  in muscle invasive bladder cancer
date: '2024-06-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38868531/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240613182215&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Muscle invasive bladder cancer (MIBC) remains a prevalent
  cancer with limited therapeutic options, obviating the need for innovative therapies.
  The epidermal growth factor receptor (EGFR) is a linchpin in tumor progression and
  presents a potential therapeutic target in MIBC. Additionally, the EGFR ligands
  AREG and EREG have shown associations with response to anti-EGFR therapy and improved
  progression-free survival in colorectal ...'
disable_comments: true
---
INTRODUCTION: Muscle invasive bladder cancer (MIBC) remains a prevalent cancer with limited therapeutic options, obviating the need for innovative therapies. The epidermal growth factor receptor (EGFR) is a linchpin in tumor progression and presents a potential therapeutic target in MIBC. Additionally, the EGFR ligands AREG and EREG have shown associations with response to anti-EGFR therapy and improved progression-free survival in colorectal ...